Ocumension Therapeutics (HKG:1477)

Hong Kong · Delayed Price · Currency is HKD

5.06

-0.09 (-1.75%)

Jul 31, 2026, 4:08 PM HKT

Ocumension Therapeutics Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	804.35	804.35	417.31	246.37	158.96	56.15
Revenue Growth	47.94%	92.75%	69.38%	54.99%	183.11%	328.73%
Gross Profit	360.92	360.92	225.07	144.37	102.92	36.94
Operating Income	-160.2	-160.2	-306.43	-402.15	-455.86	-385.93
Net Income	-158.82	-158.82	-268.27	-379.79	-402.64	-259.99
Earnings Per Share	-0.20	-0.20	-0.39	-0.59	-0.64	-0.43
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	402.46	402.46	769.21	1,054	1,314	1,785
Total Debt	187.54	187.54	25.78	137.98	29.58	11.21
Net Cash (Debt)	214.93	214.93	743.42	915.82	1,285	1,774
Net Cash Growth	-56.58%	-71.09%	-18.82%	-28.72%	-27.57%	-13.23%
Net Cash Per Share	0.27	0.27	1.09	1.41	2.03	2.92

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-105.29	-105.29	-178.83	-177.93	-200.66	-196.85
Capital Expenditures	-28.88	-28.88	-47.1	-80.91	-115.81	-195.37
Free Cash Flow	-134.17	-134.17	-225.92	-258.84	-316.47	-392.22
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	44.87%	44.87%	53.93%	58.60%	64.74%	65.78%
Operating Margin	-19.92%	-19.92%	-73.43%	-163.23%	-286.78%	-687.36%
Pretax Margin	-19.70%	-19.70%	-64.04%	-154.03%	-253.04%	-463.06%
Profit Margin	-19.74%	-19.74%	-64.29%	-154.16%	-253.30%	-463.06%
FCF Margin	-16.68%	-16.68%	-54.14%	-105.06%	-199.09%	-698.57%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	108.97	265.99	-	-	-	-
PS Ratio	4.61	6.74	8.27	17.00	37.60	169.30